181 related articles for article (PubMed ID: 11407226)
1. [Pathophysiological and pharmacotherapeutic aspects of IgE-mediated allergic reactions].
Simon HU
Ther Umsch; 2001 May; 58(5):266-73. PubMed ID: 11407226
[TBL] [Abstract][Full Text] [Related]
2. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.
Broide D
J Allergy Clin Immunol; 2008 Sep; 122(3):475-80. PubMed ID: 18694589
[TBL] [Abstract][Full Text] [Related]
3. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
Fajt ML; Wenzel SE
J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
[TBL] [Abstract][Full Text] [Related]
4. A standardized aqueous extract of Anoectochilus formosanus modulated airway hyperresponsiveness in an OVA-inhaled murine model.
Hsieh CC; Hsiao HB; Lin WC
Phytomedicine; 2010 Jul; 17(8-9):557-62. PubMed ID: 20092984
[TBL] [Abstract][Full Text] [Related]
5. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
6. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
Oki S; Miyake S
Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
[TBL] [Abstract][Full Text] [Related]
7. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
Chang TW; Wu PC; Hsu CL; Hung AF
Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
[TBL] [Abstract][Full Text] [Related]
8. Novel treatments of asthma and allergic diseases.
Chini L; Monteferrario E; Graziani S; Moschese V
Paediatr Respir Rev; 2014 Dec; 15(4):355-62. PubMed ID: 24287269
[TBL] [Abstract][Full Text] [Related]
9. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
Owen CE
Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
13. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC
J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic therapies: effects on eosinophil progenitors.
Baatjes AJ; Sehmi R; Saito H; Cyr MM; Dorman SC; Inman MD; O'Byrne PM; Denburg JA
Pharmacol Ther; 2002 Jul; 95(1):63-72. PubMed ID: 12163128
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
[TBL] [Abstract][Full Text] [Related]
16. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
17. Childhood asthma as an allergic disease: rationale for the development of future treatment.
Tang ML; Powell CV
Eur J Pediatr; 2001 Dec; 160(12):696-704. PubMed ID: 11795676
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for ocular allergy.
Leonardi A
Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
[TBL] [Abstract][Full Text] [Related]
19. Cord blood cytokines and chemokines and development of allergic disease.
Sandberg M; Frykman A; Ernerudh J; Berg G; Matthiesen L; Ekerfelt C; Nilsson LJ; Jenmalm MC
Pediatr Allergy Immunol; 2009 Sep; 20(6):519-27. PubMed ID: 19175890
[TBL] [Abstract][Full Text] [Related]
20. Anti-IgE therapy in allergic disease.
Milgrom H
Curr Opin Pediatr; 2004 Dec; 16(6):642-7. PubMed ID: 15548927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
